Tizanidne Hydrochloride Capsule
Product Images NDC 68788-8798

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 68788-8798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

FDA Label Image

Tiz03 (Tiz03)

This text provides a comparison of the improvement in Ashworth Score over time between different dosages of tizanidine (16 mg and 8 mg) and a placebo. The graph likely indicates how the Ashworth Score changes hours after taking each respective dosage.*

FDA Label Image

Tiz04 (Tiz04)

This text discusses the improvement in the Ashworth Score during a study involving Tizanidine. The study conducted over a period of 7 weeks shows the mean dose of 26.8 mg of Tizanidine. The Ashworth Score was monitored from the end of titration in week 3 to the end of maintenance in week 7 using the Last Observation Carried Forward method.*

FDA Label Image

Tizanidine Hydrochloride Capsules 4mg (Tiz08new 1)

Description not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.